Multiple effects of presumed glutathione depletors on rabbit proximal tubules. The role of glutathione (OSH) in the protection of normal renal function has heen investigated using rabbit proximal tubules. Compounds known to deplete GSH in various biological systems by alkylation (via USH S-transferases, phorone; 2-cyclohexen-l-one, CMX; diethyl maleate, DEM) or by inhibiting GSH synthesis (buthionine sulfoximine, BSO) were added to suspensions of proximal tubules and incubated for 60 mi BSO (1 or 5 mM) did not decrease GSH concentrations, 02 consumption, or cause lactate dehydrogenase release (LDH). Concentrations of CHX (2 mM) and phorone (10 mM) that decreased GSH concentrations also inhibited 02 consumption and caused LDH release. DEM (10 mM) did not significantly decrease GSH concentrations but did inhibit oxygen consumption and cause slight LDH release, Time-course studies using CMX (3 msi) showed that GSH levels and 02 consumption decreased as early as 15 mm while LDH release did not occur until 60 mm. These results show that: I) there may be a relationship between 02 consumption and GSH levels; 2) agents that have been used historically to reduce GSH concentrations have other cytotoxic effects; and 3) rabbit renal proximal tubules appear to be resistant to GSH depletion.
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The tripeptide glutathione (GSH) is found in high concentrations in mammalian cells and is thought to function directly or indirectly in many cellular reactions [1] . The kidney contains the biosynthetic and degradation enzymes involved in USH metabolism and plays a major role in the interorgan metabolism of GSH [1] [2] [3] . However, the role of OSH in normal kidney function has not been extensively addressed. Suggestive evidence has linked GSH to several physiological functions in renal proximal tubules, including a role in intermediary metabolism, cellular respiration, gluconeogenesis and electrolyte movements. For example, Leibach et al 1 4] reported that diamide-induced decreases in intracellular GSH concentration resulted in an inhibition of Na,K-ATPase activity, amino acid uptake, gluconeogenesis and a decrease in sodium content in renal cortical slices. Diamide, however, also has many other effects, including non-specific oxidation of cellular macromolecules, inhibition of cellular respiration, mitochondrial swelling and altering cell membrane permeability [5] . Thus, the effects seen by Leibach et al [4] may have not resulted specifically from GSH depletion.
Received for publication April 8, 1985 , and in revised form July 15, 1985 © 1986 by the International Society of Nephrology Brezis et al [6] reported that "selective" GSH depletion can be induced in the isolated, perfused rat kidney. "Selective" USH depletion was accomplished by either inhibiting GSH synthesis using the y-glutamylcysteine synthetase inhibitor buthionine sulfoximine (BSO) or by alkylating GSH using diethyl maleate (DEM) or 2-cyclohexen-1-one (CHX) [7] . DEM and CHX interact with GSH by direct conjugation and/or via the glutathione S-transferases to form a GSH adduct [8] . Their results showed that GSH depletion was associated with an increase in sodium excretion (up to sevenfold), an increase in potassium excretion (up to 2.6-fold) and a decrease in concentrating ability. The increases in the fractional excretion of sodium and potassium could result from altered transport processes in the proximal tubules.
The purpose of this work was to study the role of GSH in normal renal function at the cellular level. By using a well defined suspension of proximal tubules with open lumens [9] , it was possible to examine the role(s) of OSH in renal function without the complication of hydrodynamic effects and multiple cell types found in whole kidney preparations. GSH concentrations in the tubules were modified by either inhibiting GSH synthesis using BSO or by alkylating GSH using DEM, CHX or phorone. Phorone (2,6-dimethyl-2,5-heptadiene-4-one) is another chemical that can interact with GSH via glutathione S-transferases to form GSH adducts [10] . Following the addition of these compounds the quantity of respiration available to support Na,K-ATPase-mediated ion transport, intracellular OSH and lactate dehydrogenase (LDH) release were monitored to determine tubular dysfunction.
Methods
Renal tubule suspension. Renal proximal tubules from female New Zealand white rabbits (3 to 4 kg) were isolated according to Soltoff and Mandel [9] with the following modification. Dextran was omitted from all buffers following the in situ perfusion. Tubules were resuspended (4 to S mg cellular protein/ mliter) in a buffer containing (in mM): 115 NaC1, 25 NaHCO3, 2 NaH2PO4, 1 CaCl2, 5 KC1, I MgSO4, 5 glucose, 4 sodium lactate, 1 alanine, 5 sodium malate, and 2 sodium butyrate (pH 7.4).
Incubations of lubules. Tubules resuspended in the above solution were incubated at 37°C and continuously gassed with 95% 02/5% CO2 in a gyrating shaker bath for 15 mm before the addition of the OSH depletors. Various concentrations of the OSH depletors were added (time 0) and the cells were allowed to incubate for an additional 60 mm unless otherwise stated. In incubations in which BSO was added with a GSH alkylating agent, the BSO was added at time -5 mm. Additional sodium butyrate was added at time 30 mm for a final concentration of 2 mM. DEM, CHX and phorone were dissolved in dimethyl sulfoxide and BSO was dissolved in distilled water. The final volume of DMSO or distilled water added to the incubation was less than 1 percent. At the appropriate time points, aliquots of the tubule suspension were taken for 02 consumption, LDH release and GSH concentrations.
GSH assay. Aliquots (1.0 mliter) of the tubule suspension were layered on 0.4 mliter of a mixture of dibutyl phthalate and dioctyl phthalate (2:1) and centrifuged for 2 mm in an Eppendorf microcentrifuge. Following the removal of the buffer and phthalate layer, the pellet was resuspended in 1.0 muter of 0.1 M sodium phosphate to 0.005 M EDTA buffer (pH 8.0). Samples were then frozen and thawed three times, and an aliquot taken for protein determination. Samples were then centrifuged again for 2 mm in an Eppendorf centrifuge. An aliquot (0.1 muter) of the resulting supernatant was added to 3.1 mliter of fresh phosphate-EDTA buffer and the amount of GSH determined by the method of Hissin and Hilf [11] . LDH assay. An aliquot (1.0 mliter) of the tubule suspension was layered on 0.4 mliter of dibutylldioctyl phthalate and centrifuged for 2 mm in an Eppendorf microcentrifuge. 0.5 mliter of the supernatant was transferred to a new tube and was frozen and thawed three times. In parallel, 0.5 mliter of the tubule suspension was frozen and thawed three times. LDH activity was determined by the method of Bergmeyer et al [12] . LDH activity was expressed as the percentage of activity found in the media to the total activity. Oxygen consumption. The rate of respiration of the tubule suspension was monitored using a Clark-type oxygen electrode and an oxymeter. The 1.6 mliter magnetically-stirred chamber was thermostatically set at 37°C. Nystatin-stimulated respiration was determined by adding approximately 1400 units of nystatin to the chamber after obtaining a control respiratory rate. To obtain the respiration rate not coupled to Na,KATPase activity, ouabain (10-a M final concentration) was added to the chamber.
Protein content. Protein content was determined by the biuret method [13] following solubilization in 0.2 M NaOH/10%
deoxycholate. Bovine serum albumin was used as the protein standard. Chemicals. Mycostatin (nystatin) was purchased from Behring Diagnostics Corp. (San Diego, California, USA) and was dissolved in dimethyl sulfoxide. Dextran T-40 and Ficoll were obtained from Pharmacia Fine Chemicals (Piscataway, New Jersey, USA). Collagenase (Type 1A), Protease (Type XIV), GSH, DEM and ouabain were purchased from Sigma Chemical Co. (St. Louis, Missouri, USA). Phorone (2,6-dimethyl-2,5-heptadien-4-one), dimethyl suifoxide and 2-cyclohexen-1-one were obtained from Aldrich Chemical Co. (Milwaukee, Wisconsin, USA). All other chemicals were reagent grade.
Statistics. The data are presented as the mean SEM (N = 3 to 7). The data were either analyzed by one-way analysis of variance with the means being compared by Fisher's protected least significant difference procedure or the paired Students t test [14] . A P value of less than 0.05 was considered significant.
Results

Buthionine sulfoximine
The addition of BSO (1 or 5 mM) to a suspension of rabbit proximal tubules did not result in a reduction in GSH concentrations in 60 mm incubations (Fig. 1) . While there was no effect on GSH concentrations, 5 mM BSO caused a small decrease in the amount of LDH released when compared to controls (7.9% to 4.9%). In addition, 5 mrvi BSO caused a 25% increase in the ouabain-sensitive nystatin-stimulated rate of oxygen consumption (NYS-Q02) in the tubules. The NYS-Q02 is a measure of the quantity of respiration available to support Na,K-ATPase mediated ion transport and thus is a sensitive indicator of ion transport and cellular health [15] . Phorone controls. These results suggest that phorone does not act specifically to reduce GSH concentrations in this tissue and The addition of 2 or 5 m phorone to the proximal tubules did concentrations that do deplete GSH are also cytotoxic. not result in any change in GSH concentrations or in the NYS-Q02 when compared to controls (Fig. 2 ) However, Diethyl inaleate phorone at a concentration of 10 m caused a 55% decrease in
The effects of DEM on proximal tubules were more complex GSH concentrations and a 93% decrease in the NYS-Q02. than those seen with BSO and phorone (Fig. 3) . GSH concenThese changes were associated with a large decrease in cell trations were not altered by DEM over a concentration range of viability as measured by 75% LDH release. The disproportional 2 to 10 mM. LDH release only increased over controls at a DEM change in LDH release compared to OSH can be explained by concentration of 10 ms'i (8.1% to 14.3%). As with 10 mM the method used to separate the tubules from the medium. Only phorone, the discrepancy seen between GSH concentrations cells that are "functionally" intact will pass through the phthal-and LDH release can be explained by the phthalate separation ate layer, thereby selecting less damaged cells. When GSH procedure. When GSH concentrations are expressed as percent concentrations are expressed as percent of control and not of control and not normalized for mg protein, intracellular GSH normalized for mg protein, intracellular GSH is 8 2% of is 90% of controls. At low concentrations of DEM (2 mM), NYS-Q02 was increased (21.2 vs. 17.3). However at a concentration of 10 msi, DEM inhibited NYS-Q02 by 60%.
GSH depletion was then attempted by adding both a GSH alkylating agent (DEM) and a GSH synthesis inhibitor (BSO). The combination of 5 mst DEM and 5 mt,s BSO did not result in a decrease in GSH concentrations. However, the combination did result in a small decrease in NYS-Q02 and a small increase in LDH leakage compared to 5 mrs DEM alone (Fig. 3) . These results suggest that DEM, like phorone, does not specifically reduce GSH concentrations in this tissue, but is capable of eliciting other cytotoxicities.
2-Cyclohexen-1 -one GSH concentrations in the proximal tubules were not altered by CHX until a concentration of 2 m was used (Fig. 4) , which caused a 25% reduction in GSH concentrations. Lower concentrations of CHX (0.5 mii and 1 ruM) inhibited NYS-Q02 17% and 64%, respectively. Furthermore, a 1 m concentration of CHX caused a small increased in LDH leakage, as compared to controls.
GSH depletion was then attempted by adding both CHX and BSO. The combination of 0.5 mrt CHX and 5 mtt BSO did not change GSH concentrations, Q02 or LDH release when compared to 0.5 mri CHX (Fig. 4) .
To determine the sequence of events elicited by CHX, a concentration of CHX was added (3 mM) to proximal tubules that caused changes in GSH concentration, NYS-Q02 and LDH release and samples were taken over time (15, 30 and 60 mm). Under these conditions, GSH concentrations as well as the NYS-Q02 decreased within 15 mm and continued to decrease throughout the 60 mm incubation (Fig. 5) . In contrast, LDH leakage, as measured by LDH activity, retention by the tubules as percent of controls did not occur until the 60 mm time point. These data show that reductions in GSH concentrations and NYS-Q02 caused by CHX are early events in CHX-induced cytotoxicity and that LDH release occurs at later time points.
Discussion
The compounds used to reduce GSH concentrations in this study have also been used in other tissues in vitro and in vivo.
For example, BSO (4 mM), DEM (1 mM) and phorone (0.5 mM) decreased GSH concentrations in hepatocytes in 30 mm or less [10, 16, 17] . However, unlike hepatocytes, the incubation of CHX, DEM and phorone with rabbit renal proximal tubules only resulted in reducing GSH concentrations when they also caused plasma membrane damage, as measured by LDH release, and inhibited cellular respiration. CHX was the most potent cytotoxicant followed by DEM and phorone. Attempts to reduce GSH concentrations by adding both an alkylating type of depletor and a synthesis inhibitor were unsuccessful in decreasing GSH concentrations, compared to the alkylating agent alone.
Experiments examining the time-dependent changes caused by 3 ma'i CHX suggested that reductions in GSH concentrations and inhibition of oxygen consumption were early changes induced by this compound and preceded plasma membrane damage as measured by LDH release. While the time-dependent study could not determine whether a decrease in GSH concentrations preceded a reduction in cellular respiration, the caused a small decrease in the amount of LDH released when added to the tubules.
While the Brezis et al [6] study using the isolated perfused rat kidney did not demonstrate a cause and effect relationship between GSH reductions and altered renal function, there was an association between OSH reductions and altered renal function. Our results suggest that some of the results seen in the rat kidney may be due to nonspecific effects of these compounds. For example, CHX may cause plasma membrane permeability changes which could result in an increase in sodium and potassium excretion. Furthermore, by inhibiting respiration and thus decreasing the amount of ATP available for the Na,K-ATPase, an increased sodium excretion may result. With a large increase in ion excretion it is not surprising that concentrating ability decreases. However, the differences between this study and Brezis et al [6] may also be explained by the differences in the species and experimental model.
While the lack of an effect by CHX, DEM and phorone is puzzling, one possible explanation is that rabbit proximal tubules have a low concentration of GSH S-transferases or the isozymes of GSH S-transferases responsible for the metabolism of these compounds.
In summary, the data suggest there may be a relationship between GSH concentrations and QO2. Recent experiments (manuscript in preparation) using 2-bromohydroquinone support this hypothesis. Agents that have been used historically to reduce OSH concentrations can have other cytotoxic effects and must be used cautiously. Finally, rabbit renal proximal tubules appear to be more resistant to GSH depletion than hepatocytes.
